ZNF827 Activators
ZNF827 activators are chemical compounds that enhance the functional activity of the ZNF827 protein, a member of the zinc finger protein family characterized by the presence of zinc finger motifs that can bind to DNA and influence transcription. For example, certain small molecule ligands that target the DNA-binding domain of ZNF827 can stabilize the protein-DNA complex, thereby enhancing its transcriptional regulatory function. Other activators may work by affecting post-translational modifications of the ZNF827 protein; phosphorylation-inducing compounds can lead to an augmentation of ZNF827's binding affinity to its target DNA sequences, thus promoting gene expression patterns that are under the regulatory domain of ZNF827.
Furthermore, the suite of ZNF827 activators also includes compounds that modulate the cellular milieu to favor the activity of ZNF827. This modulation may involve the alteration of intracellular zinc concentrations, which is critical for the structural integrity and binding capability of zinc finger domains. Altering the balance of metal ions within the cell can, therefore, result in an enhanced activity of ZNF827, giving it a more robust role in gene regulation. Additionally, activators that influence the proteostasis network can ensure the stability and proper folding of ZNF827, contributing to its sustained activity. By preventing the degradation or misfolding of ZNF827, these chemical compounds indirectly ensure that the protein can continuously exert its regulatory effects on gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylyl cyclase, which increases intracellular levels of cAMP. Elevated cAMP can enhance the activity of ZNF827 by promoting phosphorylation events that increase its binding affinity to DNA, thereby influencing gene expression regulation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can prevent the degradation of transcription factors and regulatory proteins. By stabilizing the proteins that interact with ZNF827, MG132 may enhance the functional stability and activity of ZNF827 in gene regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate is another histone deacetylase inhibitor, promoting a relaxed chromatin state, which could enhance the binding efficiency of ZNF827 to DNA and thus its functional activity in the regulation of gene expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate a multitude of substrates, including those that may interact with ZNF827. This phosphorylation can enhance the ZNF827 protein-protein interactions, potentially augmenting its functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit DNA methyltransferases, potentially leading to reduced methylation of DNA and enhanced access of ZNF827 to its target sites, thereby improving its gene regulatory functions. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid can modulate gene expression by acting on retinoic acid receptors which can influence chromatin remodeling. This remodeling may increase the accessibility of target gene promoters to ZNF827, thereby enhancing its functional activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor, which displaces BET proteins from acetylated histones, potentially allowing for increased binding of ZNF827 to its target gene promoters due to reduced competition and enhanced chromatin accessibility, leading to increased gene regulatory activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride can inhibit GSK-3, which may prevent the phosphorylation and subsequent degradation of proteins that interact with or regulate ZNF827, thus potentially enhancing the stability and activity of ZNF827. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, influencing various calcium-dependent signaling pathways. Increased calcium may enhance the activity of ZNF827 through the activation of calcium-dependent protein kinases that could phosphorylate ZNF827 or its associated factors, thereby influencing its gene regulatory functions. | ||||||